<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font24 { font-size : 24; } .font25 { font-size : 25; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">antibody </span>
   <span class="font25">EBOV </span>
   <span class="font24">plasma </span>
   <span class="font21">antibodies </span>
   <span class="font19">following </span>
   <span class="font18">infection </span>
   <span class="font18">vaccination </span>
   <span class="font18">ChAd-MVA </span>
   <span class="font18">binding </span>
   <span class="font17">antigenic </span>
   <span class="font16">samples </span>
   <span class="font16">sites </span>
   <span class="font16">survivors </span>
   <span class="font15">Ebola </span>
   <span class="font15">vaccine </span>
   <span class="font15">virus </span>
   <span class="font15">(Figure </span>
   <span class="font14">generated </span>
   <span class="font14">study </span>
   <span class="font14">survivor </span>
   <span class="font14">compared </span>
   <span class="font14">{border-style </span>
   <span class="font14">(#) </span>
   <span class="font14">affinity </span>
   <span class="font14">epitope </span>
   <span class="font14">response </span>
   <span class="font13">human </span>
   <span class="font13">post-vaccination </span>
   <span class="font13">px;} </span>
   <span class="font13">sample </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">SPR </span>
   <span class="font13">post-infection </span>
   <span class="font13">recognized </span>
   <span class="font13">(GP </span>
   <span class="font13">GFPDL </span>
   <span class="font13">IgG </span>
   <span class="font13">repertoire </span>
   <span class="font12">epitopes </span>
   <span class="font12">neutralization </span>
   <span class="font12">prime-boost </span>
   <span class="font12">terminus </span>
   <span class="font12">(#, </span>
   <span class="font12">Khurana </span>
   <span class="font12">polyclonal </span>
   <span class="font12">showed </span>
   <span class="font12">using </span>
   <span class="font12">S). </span>
   <span class="font12">peptide </span>
   <span class="font12">Antibody </span>
   <span class="font12">Figure </span>
   <span class="font12">demonstrated </span>
   <span class="font12">peptides </span>
   <span class="font12">GP, </span>
   <span class="font12">ebola </span>
   <span class="font12">frequency </span>
   <span class="font12">fusion </span>
   <span class="font12">higher </span>
   <span class="font12">immune </span>
   <span class="font12">isotype </span>
   <span class="font12">observed </span>
   <span class="font12">shown </span>
   <span class="font12">titers </span>
   <span class="font11">(Khurana </span>
   <span class="font11">GP-binding </span>
   <span class="font11">IgM </span>
   <span class="font11">convalescent </span>
   <span class="font11">different </span>
   <span class="font11">individual </span>
   <span class="font11">months </span>
   <span class="font11">obtained </span>
   <span class="font11">vaccinated </span>
   <span class="font11">versus </span>
   <span class="font11">â€“), </span>
   <span class="font11">(site </span>
   <span class="font11">-fold </span>
   <span class="font11">EBOV-GP </span>
   <span class="font11">EVD </span>
   <span class="font11">Med. </span>
   <span class="font11">Plasma </span>
   <span class="font11">diverse </span>
   <span class="font11">identified </span>
   <span class="font11">individuals </span>
   <span class="font11">induced </span>
   <span class="font11">pooled </span>
   <span class="font11">protection </span>
   <span class="font11">px; </span>
   <span class="font11">sequence </span>
   <span class="font11">sera </span>
   <span class="font11">similar </span>
   <span class="font11">site </span>
   <span class="font11">{font-family </span>
   <span class="font11">MAb </span>
   <span class="font11">acid </span>
   <span class="font11">amino </span>
   <span class="font11">anti-GP </span>
   <span class="font11">clinical </span>
   <span class="font11">clones </span>
   <span class="font11">dissociation </span>
   <span class="font11">domain </span>
   <span class="font11">font-size </span>
   <span class="font11">high </span>
   <span class="font11">novel </span>
   <span class="font11">overall </span>
   <span class="font11">possible </span>
   <span class="font11">titer </span>
   <span class="font11">total </span>
   <span class="font11">used </span>
   <span class="font11">vaccination. </span>
   <span class="font11">#), </span>
   <span class="font11">Antibodies </span>
   <span class="font11">Antigenic </span>
   <span class="font11">EBOV/Makona </span>
   <span class="font11">Engl. </span>
   <span class="font11">Infection </span>
   <span class="font11">Leone </span>
   <span class="font11">Sierra </span>
   <span class="font11">Vaccination </span>
   <span class="font11">anti-GP-binding </span>
   <span class="font11">described </span>
   <span class="font11">did </span>
   <span class="font11">disease </span>
   <span class="font11">double; </span>
   <span class="font11">humans </span>
   <span class="font11">influenza </span>
   <span class="font11">performed </span>
   <span class="font11">phage </span>
   <span class="font11">previously </span>
   <span class="font11">rVSV-EBOV </span>
   <span class="font11">resonance </span>
   <span class="font11">A). </span>
   <span class="font11">GP), </span>
   <span class="font11">Human </span>
   <span class="font11">IgG, </span>
   <span class="font11">Infect. </span>
   <span class="font11">MLD </span>
   <span class="font11">Survivors </span>
   <span class="font11">Transparent </span>
   <span class="font11">V., </span>
   <span class="font11">ZMapp </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">bound </span>
   <span class="font11">cap </span>
   <span class="font11">class </span>
   <span class="font11">control </span>
   <span class="font11">determined </span>
   <span class="font11">dilutions </span>
   <span class="font11">diversity </span>
   <span class="font11">expressing </span>
   <span class="font11">fingerprint </span>
   <span class="font11">gene </span>
   <span class="font11">global </span>
   <span class="font11">glycan </span>
   <span class="font11">highly </span>
   <span class="font11">homologous </span>
   <span class="font11">identify </span>
   <span class="font11">including </span>
   <span class="font11">lethal </span>
   <span class="font11">measured </span>
   <span class="font11">monovalent </span>
   <span class="font11">neutralizing </span>
   <span class="font11">nonhuman </span>
   <span class="font11">number </span>
   <span class="font11">outbreak </span>
   <span class="font11">phase </span>
   <span class="font11">preferentially </span>
   <span class="font11">previous </span>
   <span class="font11">protein </span>
   <span class="font11">provide </span>
   <span class="font11">receive </span>
   <span class="font11">recombinant </span>
   <span class="font11">red; </span>
   <span class="font11">solid; </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">(A) </span>
   <span class="font10">(B) </span>
   <span class="font10">(C) </span>
   <span class="font10">(Figures </span>
   <span class="font10">(Fuentes </span>
   <span class="font10">(Table </span>
   <span class="font10">(sample </span>
   <span class="font10">./s </span>
   <span class="font10">B). </span>
   <span class="font10">Binding </span>
   <span class="font10">EBOV-GFPDL </span>
   <span class="font10">EBOV-infected </span>
   <span class="font10">However, </span>
   <span class="font10">MAbs </span>
   <span class="font10">Moreover, </span>
   <span class="font10">PsVN </span>
   <span class="font10">SPR. </span>
   <span class="font10">Total </span>
   <span class="font10">VII </span>
   <span class="font10">adenovirus </span>
   <span class="font10">analyses </span>
   <span class="font10">analysis </span>
   <span class="font10">assay </span>
   <span class="font10">bars </span>
   <span class="font10">based </span>
   <span class="font10">blue; </span>
   <span class="font10">bold </span>
   <span class="font10">contained </span>
   <span class="font10">correlated </span>
   <span class="font10">correlation </span>
   <span class="font10">correlations </span>
   <span class="font10">courier; </span>
   <span class="font10">development </span>
   <span class="font10">effective </span>
   <span class="font10">em; </span>
   <span class="font10">experimental </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">independent </span>
   <span class="font10">infection. </span>
   <span class="font10">ongoing </span>
   <span class="font10">patients </span>
   <span class="font10">pattern </span>
   <span class="font10">phages </span>
   <span class="font10">pink </span>
   <span class="font10">protective </span>
   <span class="font10">protects </span>
   <span class="font10">pt;} </span>
   <span class="font10">qualitative </span>
   <span class="font10">repertoires </span>
   <span class="font10">representing </span>
   <span class="font10">samples. </span>
   <span class="font10">selected </span>
   <span class="font10">specificity </span>
   <span class="font10">stomatitis </span>
   <span class="font10">strain </span>
   <span class="font10">study, </span>
   <span class="font10">surface </span>
   <span class="font10">time </span>
   <span class="font10">titers. </span>
   <span class="font10">treatment </span>
   <span class="font10">vaccination-induced </span>
   <span class="font10">vitro </span>
  </p>
 </body>
</html>
